| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | $0.00 |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | – | – | – | – | – |
| R&D | $9.80M | $3.60M | $3.31M | $2.67M | $1.56M |
| SG&A | $6.49M | $5.93M | $6.07M | $6.58M | $4.50M |
| Operating Income | – | – | – | – | – |
| Interest Expense | – | – | – | – | $1.09M |
| Tax Expense | – | – | – | – | – |
| Net Income | -$15.80M | -$8.96M | -$8.69M | -$9.38M | -$21.46M |
| EPS (basic) | – | – | – | – | -0.0100 |
| EPS (diluted) | – | – | – | – | -0.0100 |
| Shares (diluted) | – | – | – | – | $1.58B |